A Multicenter Cohort Study of Dose-Dense Temozolomide (21 of 28 Days) for the Treatment of Recurrent Anaplastic Astrocytoma or Oligoastrocytoma

By Neyns Bart   Chaskis Cristo   Joosens Eric   Menten Johan   D'Hondt Lionel   Branle Fabrice   Sadones Jan   Michotte Alex  

Cancer Investigation, Vol. 26, Iss. 3, 2008-03 ,pp. : 269-277

Informa Healthcare

Access to resources Recommend Favorite

Cytoplasmic Crystalline Inclusions in a Anaplastic Oligoastrocytoma

By Kim Min-Kyung   Joo Mee   Kim Hanseong   Park Sung-Hye   Chi Je  

Ultrastructural Pathology, Vol. 28, Iss. 3, 2004-05 ,pp. : 159-163

Informa Healthcare

Access to resources Recommend Favorite

Prognosis in patients with anaplastic oligoastrocytoma is associated with histologic grade

By Buckner Jan   O’Fallon Judith   Dinapoli Robert   Schomberg Paula   Farr Gist   Schaefer Paul   Giannini Caterina   Scheithauer Bernd   Ballman Karla  

Journal of Neuro-Oncology, Vol. 84, Iss. 3, 2007-09 ,pp. : 279-286

Springer Publishing Company

Access to resources Recommend Favorite

Up-front temozolomide in elderly patients with anaplastic oligodendroglioma and oligoastrocytoma

By Ducray François   Sierra del Rio Monica   Carpentier Catherine   Psimaras Dimitri   Idbaih Ahmed   Dehais Caroline   Kaloshi Gentian   Mokhtari Karima   Taillibert Sophie   Laigle-Donadey Florence   Omuro Antonio   Sanson Marc   Delattre Jean-Yves   Hoang-Xuan Khê  

Journal of Neuro-Oncology, Vol. 101, Iss. 3, 2011-02 ,pp. : 457-462

Springer Publishing Company

Access to resources Recommend Favorite

Synchronous osteoclastoma and anaplastic astrocytoma: A case report

By Li Binhua   Zhang Bin   Ren Weiqi   Xiao Xiang   Dai Min  

Oncology Letters, Vol. 6, Iss. 5, 2013-11 ,pp. : 1299-1302

Spandidos Publications

Access to resources Recommend Favorite